[
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Monday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=730dc0b0936a26f5c1bfcff2fa6fcd23abddd5eb152e4d4d6b50843a61cb346a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731947940,
      "headline": "Amgen Inc. stock underperforms Monday when compared to competitors",
      "id": 131474882,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=730dc0b0936a26f5c1bfcff2fa6fcd23abddd5eb152e4d4d6b50843a61cb346a"
    }
  },
  {
    "ts": null,
    "headline": "Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?",
    "summary": "We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other immunotherapy stocks. The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by […]",
    "url": "https://finnhub.io/api/news?id=2751f339dce6bc9230789a1a590c4de1de1668435674063465a857d0fd876153",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731941043,
      "headline": "Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?",
      "id": 131448575,
      "image": "https://s.yimg.com/ny/api/res/1.2/Umivb7Omy8VqKH22zTmY9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other immunotherapy stocks. The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by […]",
      "url": "https://finnhub.io/api/news?id=2751f339dce6bc9230789a1a590c4de1de1668435674063465a857d0fd876153"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Sells Off: Keep Calm And Buy The Dip",
    "summary": "Analyzing Amgen's stock drop, management's response, and potential for growth in GLP-1 candidate MariTide in a volatile market. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=12ed5b0ff582f7e34554759e9bd8a92ed917dc12788bdb1d4e2fb8553e9ced87",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731940920,
      "headline": "Amgen Sells Off: Keep Calm And Buy The Dip",
      "id": 131459097,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418324349/image_1418324349.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Analyzing Amgen's stock drop, management's response, and potential for growth in GLP-1 candidate MariTide in a volatile market. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=12ed5b0ff582f7e34554759e9bd8a92ed917dc12788bdb1d4e2fb8553e9ced87"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=bb9762ff6a7f7b3b5c553abe7265d16f914f79ad3ba8eab265dfc16b237154cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731938412,
      "headline": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 131448619,
      "image": "https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=bb9762ff6a7f7b3b5c553abe7265d16f914f79ad3ba8eab265dfc16b237154cb"
    }
  },
  {
    "ts": null,
    "headline": "Nike, NVIDIA Corp. share losses lead Dow's 111-point drop",
    "summary": "Nike, NVIDIA Corp. share losses lead Dow's 111-point drop",
    "url": "https://finnhub.io/api/news?id=c0b5ad194e10c40561f99dc3d577650421b735042be14c583978c79bd6cd32d8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731925260,
      "headline": "Nike, NVIDIA Corp. share losses lead Dow's 111-point drop",
      "id": 131443333,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Nike, NVIDIA Corp. share losses lead Dow's 111-point drop",
      "url": "https://finnhub.io/api/news?id=c0b5ad194e10c40561f99dc3d577650421b735042be14c583978c79bd6cd32d8"
    }
  }
]